Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 20

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 20
---
, and the delisting of APx’s Class A ordinary shares will become effective on March31, 2025. In order to complete the delisting process with respect to APx’s units and warrants, APx expects that Nasdaq will file a Form 25 -NSEin respect of such securities with the SEC, and the delisting will become effective ten days after such Form 25 -NSEis filed. Although APx expects that it will be notified by Nasdaq prior to the filing of such Form 25 -NSE, as well as prior to the release of a press release by Nasdaq announcing the delisting event, APx is not at this time able to determine when such Form 25 -NSEwill be filed or when the delisting of APx’s units and warrants from Nasdaq will be complete. However, the filing of the Form 25 -NSEby Nasdaq and the subsequent delisting of APx’s units and warrants may occur at any time without prior notice. This proxy statement/prospectus provides shareholders of APx with detailed information about the Business Combination and other matters to be considered at the Special Meeting. APx encourages you to read this entire document, including the annexes and other documents referred to herein, carefully and in their entirety. It also contains or references information about APx, the Company and certain related matters. You are encouraged to read this proxy statement/prospectus carefully. In particular, when you consider the recommendation regarding these Proposals by the board of directors of APx, you should keep in mind that APx’s Initial Shareholders (as defined below) and current officers, directors and advisors, and the Company’s current shareholders have interests in the Business Combination that are different from or in addition to, or may conflict with, your interests as a shareholder. For instance, Initial Shareholders and current officers, directors and advisors, and the Company’s current shareholders will benefit from the completion of the Business Combination and may be incentivized to complete an acquisition on terms less favorable to shareholders rather than liquidating APx. See the section of this proxy statement/prospectus entitled “ Questions and Answers About the Business Combination and the Special Meeting — What interests do our Initial Shareholders, current officers, directors and advisors, and the Company’s current shareholders have in the Business Combination?” for a further discussion of these considerations. You should also carefully consider the risk factors described under the heading “ Risk Factors” beginning on page 24 of this proxy statement/prospectus. ____________ 1Note to